COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2302: Articles 23011-23020  | Next

SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
Haagmans, B. L., Noack, D., Okba, N. M. A., LI, W., Wang, C., Bestebroer, T., de Vries, R., Herfst, S., de Meulder, D., van Run, P., Lamers, M. M., Rijnders, B., Rokx, C., van Kuppeveld, F. J. M., Grosveld, F., Drabek, D., GeurtsvanKessel, C., Koopmans, M., Bosch, B. J., Kuiken, T., Rockx, B.
10.1101/2020.08.24.264630 — Posted: 2020-08-24
An hACE2 peptide mimic blocks SARS-CoV-2 Pulmonary Cell Infection
Karoyan, P., Vieillard, V., Odile, E., Denis, A., Gomes-Morales, L., Grondin, P., Lequin, O.
10.1101/2020.08.24.264077 — Posted: 2020-08-24 Discussion: Onsite
Dynamics of the N-terminal domain of SARS-CoV-2 nucleocapsid protein drives dsRNA melting in a counterintuitive tweezer-like mechanism
Caruso, I. P., Sanches, K., Da Poian, A., Pinheiro, A., Almeida, F. C. L.
10.1101/2020.08.24.264465 — Posted: 2020-08-24
A negative feedback model to explain regulation of SARS-CoV-2 replication and transcription
Shan, G., Zhi, C., Xiufeng, J., Fang, W., Yibo, X., Hao, Z., Chang, L., Jishou, R., Guangyou, D., Xin, L.
10.1101/2020.08.23.263327 — Posted: 2020-08-24
Versatile, Multivalent Nanobody Cocktails for Highly Efficient SARS-CoV-2 Neutralization
Shi, Y.
10.1101/2020.08.24.264333 — Posted: 2020-08-24 Discussion: Onsite
Discovery of drugs to treat cytokine storm-induced cardiac dysfunction using human cardiac organoids
Mills, R. J., Humphrey, S. J., Fortuna, P. R., Quaife-Ryan, G. A., Mehdiabadi, N. R., Devilee, L., Voges, H. K., Reynolds, L. T., Krumeich, S., Mathieson, E., Griffen, B., Titmarsh, D. M., Porrello, E. R., Smyth, M. J., Engwerda, C. R., MacDonald, K. P., Bald, T., James, D. E., Hudson, J. E.
10.1101/2020.08.23.258574 — Posted: 2020-08-24 Discussion: Offsite
Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
Wang, P., Lau, S.-Y., Deng, S., Chen, P., Mok, B. W.-Y., Zhang, A. J., Lee, A. C.-Y., Chan, K.-H., Song, W., To, K. K.-W., Chen, J. F.-W., Yuen, K.-Y., Chen, H.
10.1101/2020.08.24.264192 — Posted: 2020-08-24 Discussion: Offsite
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing optimal formation of VLPs in presence of Nucleoprotein
Boson, B., Legros, V., Zhou, B., Mathieu, C., Cosset, F.-L., Lavillette, D., Denolly, S.
10.1101/2020.08.24.260901 — Posted: 2020-08-24 Discussion: Onsite | Offsite
Antiviral activity of lambda-carrageenan against influenza viruses in mice and severe acute respiratory syndrome coronavirus 2 in vitro
Jang, Y. J., Shin, H., Lee, M. K., Kwon, O. S., Shin, J. S., Kim, Y., Kim, M.
10.1101/2020.08.23.255364 — Posted: 2020-08-24
Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients
Westmeier, J., Paniskaki, K., Karaköse, Z., Werner, T., Sutter, K., Dolff, S., Overbeck, M., Limmer, A., Liu, J., Zheng, X., Brenner, T., Berger, M. M., Witzke, O., Trilling, M., Lu, M., Yang, D., Babel, N., Westhoff, T., Dittmer, U., Zelinskyy, G.
10.1101/2020.08.21.262329 — Posted: 2020-08-24 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).